Vaccine quality is assessed through a series of preclinical and clinical trials. Initially, preclinical tests are conducted on animal models to evaluate the vaccine's safety and immunogenicity. Following successful preclinical tests, clinical trials in humans are conducted in three phases to ensure the vaccine is safe and effective. Throughout these phases, the vaccine's quality is monitored and evaluated continuously.
